Eglucent 100Iu/ ml Catg Injection 3 ml works by ensuring rapid and consistent sugar control. It facilitates the reuptake of sugar in muscle and fat cells and thus suppresses sugar production in the liver. It helps to decrease blood sugar levels after the intake of meals. It prevents the chances of developing serious complications of diabetes. Besides this, Eglucent 100Iu/ ml Catg Injection 3 ml can be safely prescribed during the pregnancy as well as lactation stage. Eglucent 100Iu/ ml Catg Injection 3 ml helps in improving the glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage of the retina (retinopathy), impairment of kidney (nephropathy), impairment of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others.

Eglucent 100Iu/ ml Catg Injection 3 ml should be administered subcutaneously in the abdomen or thigh region. If you are not well trained to self-administer Eglucent 100Iu/ ml Catg Injection 3 ml, ask a healthcare professional to administer it. Eglucent 100Iu/ ml Catg Injection 3 ml should never be administered intravenously or in the vein.

• Hypoglycemia (low blood glucose levels)
• Injection site reactions (redness, swelling)

Store in a cool and dry place away from sunlight